Precision Business Insights
Portfolio

 

Next Generation IV Infusion Pumps Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Next Generation IV Infusion Pumps Market: By Product Type (Syringe infusion pumps, Large Volumetric Infusion Pumps, Implantable Infusion Systems, Patient Controlled Analgesia Pumps, Disposable Elastomeric Infusion Systems, Others), By Application (Analgesia, Oncology, Hematology, Diabetes, Neonatology, Neurological Disorders, Gastroenterology, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centres) and Geography

 

Market Outline

Next generation IV infusion pumps are the combination of intuitive user interface, simplicity, and state of art information technology. Next generation IV infusion pumps are inclined with the advanced pumping systems to improve the patient safety and work efficiency. A user interface is designed for next generation IV infusion pumps to diminish the programming errors to save the time and reduce in pump interactions. Next generation IV infusion pumps are frequently adopted by healthcare professionals to improve the patient safety. The other advantages with next generation IV infusion pumps include affordability, flexibility, and ease of use, scalability, targeted delivering, and safer operability among others.

 

Market Dynamics

Increase in the prevalence and incidence of diabetes, malnutrition, neurological disorders, cancers, technological advancements in the devices, and ease of usage with more safety are anticipated to fuel the next generation IV infusion pumps market. Moreover, government support for start-ups, favorable regulatory policies, and expansion in production capacity are anticipated to boost the next generation IV infusion pumps market over the forecast period. However, product recalls, medicine dispensing errors, lack of skilled professionals, and lack of standard guidelines for product usage are anticipated to hinder the growth of next generation IV infusion pumps market over the forecast years.

 

Market Scope

Next generation IV infusion pumps market is segmented on the basis of product type, application, and end user

Based on product type, the market is segmented into the following:

  • Syringe Infusion Pumps
  • Large Volumetric Infusion Pumps
  • Implantable Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Others

Based on the application, the market is segmented into the following:

  • Analgesia
  • Oncology
  • Hematology
  • Diabetes
  • Neonatology
  • Neurological Disorders
  • Gastroenterology
  • Others

Based on the end user, next generation IV infusion pumps market is segmented into the following:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

 

Market Summary

Next generation IV infusion pumps market growth driven by innovation of newer pumps with modern technologies. Majority of the market players are developing newer technologies such as wearable insulin pumps, smartphone connected insulin pumps, and implantable insulin pumps among others, which are anticipated to fuel the market. Moreover, advantages with next generation pumps such as ease of using, patient safety, and accurate dosage also expected to bolster the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by market players for increasing their revenue share in next generation IV infusion pumps market. For instance, in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration.

 

Regional Analysis

Geographically, next generation IV infusion pumps market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America next generation IV infusion pumps market is growing due to advances in healthcare infrastructure, presence of key market players and skilled professionals in the region. Europe next generation IV infusion pumps market is projected to grow at a significant rate owing to adoption of newer technologies, rise in R&D activities for the innovation of newer products, and collaboration between companies for distribution and development of newer products. Asia Pacific next generation IV infusion pumps market expected to garner significant share due to increase in prevalence of chronic diseases such as diabetes, cancer, and neurological disorders, developing healthcare infrastructure, and increase in awareness about next generation IV infusion pumps among key stakeholders in the region.

 

Competition Assessment

Some of the players in the global next generation IV infusion pumps market include:

  • Braun Melsungen AG (Germany)
  • Johnson & Johnson Services, inc. (U.S.)
  • Hoffmann-la Roche Ltd. (Switzerland)
  • Baxter International, Inc. (U.S.)
  • Zyno medical (U.S.)
  • Smiths Medical (U.S.)
  • Ivenix, Inc (U.S.)
  • Hospira (Pfizer, Inc.) (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Terumo Corporation (Japan)

 

Notable Market Developments

  • In January 2017, Ivenix, Inc. demonstrated advanced infusion pump interoperability at HIMSS 17, the system exchanges data with EMR and Alarm Management Systems to improve the patient care, quality, safety, and outcomes

 

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Braun Melsungen AG (Germany)
  • Johnson & Johnson Services, inc. (U.S.)
  • Hoffmann-la Roche Ltd. (Switzerland)
  • Baxter International, Inc. (U.S.)
  • Zyno medical (U.S.)
  • Smiths Medical (U.S.)
  • Ivenix, Inc (U.S.)
  • Hospira (Pfizer, Inc.) (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Terumo Corporation (Japan)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials